deltatrials
Terminated PHASE2 NCT00206453

Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer

An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer

Sponsor: Baylor Breast Care Center

Conditions Breast Cancer
Interventions Taxotere
Updated 6 times since 2017 Last updated: Feb 4, 2013 Started: Jan 31, 2002 Primary completion: Jan 31, 2005 Completion: Jan 31, 2005

Listed as NCT00206453, this PHASE2 trial focuses on Breast Cancer and remains terminated or withdrawn. Sponsored by Baylor Breast Care Center, it has been updated 6 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baylor Breast Care Center
  • United States Department of Defense
Data source: Baylor Breast Care Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Houston, United States